Global Canine Arthritis Treatment Market, By Type (Surgery, Drugs, Others), Route of Administration (Oral, Parenteral, Others), Treatment (Non-steroidal anti-inflammatory Medications (NSAIDs), Opioids, Stem Cell Therapy, Allogeneic Stem Cells, Autologous Stem Cells), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) - Industry Trends and Forecast to 2029
Market Analysis and Insights
Over the last few years, the market has expanded immensely as there has been significant growth in adoption of pets and awareness regarding their health. Moreover, within the forecast period the market is expected to experience tremendous growth.
- Data Bridge Market Research analyses that the canine arthritis treatment market will grow at a CAGR of 4.5% during the forecast period of 2022 to 2029. The “stem cell therapy” accounts for the largest treatment segment in the canine arthritis treatment market within the forecasted period.
Market Definition
Canine arthritis is a degenerative joint condition that affects dogs and causes inflammation in their joints as a result of excessive rubbing, cartilage damage, and long-term joint disease. Obesity, failure of bone development, and accidental injuries are some of the causes of canine arthritis in pets. Symptoms of arthritis in pets include discomfort, stiffness, swelling, and pain in joints, as well as constant rubbing of the affected area and the formation of an unwanted saliva patch.
Canine Arthritis Treatment Market Dynamics
Drivers
-
Growing Cases of Arthritis and Related Disorders
The growing cases of arthritis and related disorders will result in the expansion of the growth rate of the treatment market. Moreover, obesity in pets is becoming more common all over the world. Obesity is directly linked to osteoarthritis in dogs, which results in difficulty moving due to the increased load on joints caused by excess fat and body weight.
Moreover, the instability in the joints, ligament fracture, long term pain in the joints, excessive rubbing of the joints which increases the risk of evolving arthritis are also a growth determinant which bolster the growth of the market. Also, the increased adoption of canines (dogs) will further enhance the growth of canine arthritis treatment market.
Furthermore, availability of the treatment will expand the canine arthritis treatment market. Other factors such as increase in the demand for effective treatment procedures coupled with the advancement in technology available for the pets will positively impact the canine arthritis treatment market's growth rate.
Opportunities
Moreover, the fast approval for veterinary regenerative medicine and veterinary therapeutic drugs by FDA to repair the damaged tissues will boost new opportunities for the market's growth rate. Also, the increase in awareness regarding canine health will escalate the growth rate canine arthritis treatment market in future.
Restraints/Challenges
However, the lack of professional for the treatment of canine arthritis will impede the growth rate of canine arthritis treatment market. Additionally, the factors such as the expensive treatment and stringent drug approval process are estimated to hinder the market’s growth.
This canine arthritis treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on canine arthritis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
The canine arthritis is majorly caused by the obesity, failure of bone development, and accidental injuries in pets. According to the studies, the canine arthritis basically affects 20% of dogs over 1 year of age in North America.
Canine arthritis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Canine Arthritis Treatment Market
The outbreak of the COVID-19 pandemic has resulted in the implementation of strict lockdowns and isolation regulations across the globe, which further led to the restrictions in the non-essential vet visits. Moreover, the canine arthritis treatment market was however affected severely by the postponement of the medical operations across the globe. However, the emergence of the COVID-19 pandemic on the other hand, has increased the adoption of pets and foster applications which is projected to aid the industry growth in the forecast period.
Recent Developments
- In September 2020, The Committee for Medicinal Products for Veterinary Use (CVMP) granted Zoetis a variation in terms of marketing authorization for the veterinary medicinal product Cytopoint, which involves adding a new therapeutic indication for the treatment of pruritus associated with allergic dermatitis in dogs.
Global Canine Arthritis Treatment Market Scope
The canine arthritis treatment market is segmented on the basis of type, route of administration, treatment, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Surgery
- Drugs
- Others
On the basis of type, canine arthritis treatment market is segmented into surgery, drugs and others.
Route of Administration
- Oral
- Parenteral
- Others
On the basis of route of administration, canine arthritis treatment market is segmented into oral, parenteral and others.
Treatment
- Non-steroidal anti-inflammatory Medications (NSAIDs)
- Opioids
- Stem Cell Therapy
- Allogeneic Stem Cells
- Autologous Stem Cells
On the basis of treatment, the canine arthritis treatment market is segmented into non-steroidal anti-inflammatory medications (NSAIDS), opioids, stem cell therapy, allogeneic stem cells and autologous stem cells. Stem cell therapy is projected to grow at a significant amount within the forecasted period.
End-Users
- Hospitals
- Speciality Clinics
- Others
On the basis of end-users, the canine arthritis treatment market is segmented into hospitals, speciality clinics and others.
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
On the basis of distribution channel, the canine arthritis treatment market is segmented into hospital pharmacy, retail pharmacy and others.
Canine Arthritis Treatment Market Regional Analysis/Insights
The canine arthritis treatment market is analyzed and market size insights and trends are provided by country, type, route of administration, treatment, end-users and distribution channel as referenced above.
The countries covered in the canine arthritis treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the canine arthritis treatment market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the increasing adoption of animals and veterinary hospitals along with the increasing consumer spending on vet in this region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the increased prevalence of arthritis in dogs, accessibility of treatment and diagnostic methods and increased health awareness programs for the animals in the region.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Canine Arthritis Treatment Market Share Analysis
The canine arthritis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to canine arthritis treatment market.
Some of the major players operating in the canine arthritis treatment market are Boehringer Ingelheim International GmbH., DAIICHI SANKYO COMPANY, LIMITED, Thorne, NUTRI-VET, Liquid Health., American Regent, Inc., DSM, Elanco, Zoetis, nationalhogfarmer, Ceva, Novasep, BASF SE, Bayer AG, and Matsun Nutrition among others.
SKU-
